Skip to content
OpenCapital
Get started

Axcelis Technologies ACLS Business Segments — Research And Development Expense

Similar metrics at other companies

Lantheus Holdings logo
LNTHReportable — Research And Development Expense
$39.38M+8.4%
Onto Innovation logo
ONTOSingle Reportable — Research And Development Excluding12
$33.17M+21.1%
Lantheus Holdings logo
LNTHReportable — Other Research And Development Expense
$27.59M-1.1%
Elanco Animal Health Inc. logo
ELANReportable Segment — R&D
$97M+3.2%
Travere Therapeutics, Inc. logo
TVTXReportable Segment — R&D
$57.09M+21.8%
Guardant Health logo
GHReportable Segment — Research and development expense
$76.59M+2.3%

Other financials

Income statement

See full
Revenue$199.0M+3.3%
Gross profit$80.6M-9.2%
Operating income$8.0M-72.7%
Net income$9.2M-67.8%
EPS (diluted)$0.30-65.9%

Balance sheet

See full
Cash & equivalents$150.8M-18.0%
Total debt$72.2M-2.2%
Total equity$1.0B+1.7%
Total assets$1.4B+2.5%

Cash flow

See full
Operating cash flow$18.1M-54.4%
CapEx$1.8M-62.9%
Free cash flow$16.3M-53.2%

Valuation

See full
Market cap$5.76B+79.0%
Enterprise value$5.68B+87.0%
P/E57.1×+39.1×
P/S6.8×+3.5×

Profitability

See full
Gross margin43.6%-1.0pp
Operating margin11.6%-7.5pp
Net margin11.9%-6.6pp
FCF margin11.5%-1.3pp

Returns & leverage

See full
Return on equity9.7%-8.7pp
Debt / equity0.1×0.0×
Current ratio4.6×-1.0×

Where this comes from

Reported directly by Axcelis Technologies in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Axcelis Technologies’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Axcelis Technologies's business segments — research and development expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Axcelis Technologies's business segments — research and development expense?
Axcelis Technologies (ACLS) reported business segments — research and development expense of $28.52M in Q1 2026.
How has Axcelis Technologies's business segments — research and development expense changed year-over-year?
Axcelis Technologies's business segments — research and development expense increased by 5.1% year-over-year, from $27.13M to $28.52M.
What is the long-term trend for Axcelis Technologies's business segments — research and development expense?
Over 3 years (2022 to 2025), Axcelis Technologies's business segments — research and development expense has grown at a 11.6% compound annual growth rate (CAGR), from $78.36M to $108.96M.
What does business segments — research and development expense mean?
This metric captures the expenditures dedicated to the innovation, design, and improvement of ion implantation systems and related processing technologies. It reflects the company's commitment to maintaining a competitive edge in the semiconductor equipment market through continuous product development.